Skip to content
Screener

CME Group CME Q4 2025 Annual earnings

Reported February 4, 2026 · Before market open

Revenue$1.6BBeat by $1.4M
EPS$2.77Beat by $0.02
Revenue estimate$1.6B
EPS estimate$2.75

Next report

Oct 21, 2026 (In 2 weeks)
Revenue estimate$1.7B
EPS estimate$2.93

Financials

Q4 2025

Income statement

See full
Revenue$1.6B+8.1%
Operating income$1.0B+7.7%
Net income$1.2B+34.3%
EPS (diluted)$3.24+35.0%

Balance sheet

See full
Cash & equivalents$4.4B+52.7%
Total debt$3.8B-1.7%
Total equity$28.7B+8.5%
Total assets$198.42B+44.4%

Cash flow

See full
Operating cash flow$1.1B+11.4%
CapEx$32.5M+24.0%
Free cash flow$1.1B+11.1%

Valuation & ratios

Valuation

as of 12/31/25
See full
Market cap$98.47B+17.7%
Enterprise value$97.81B+15.6%
P/E24.2×+0.4×
P/S15.1×+1.5×

Profitability

See full
Operating margin64.9%+0.7pp
Net margin62.5%+4.9pp
FCF margin64.3%+5.6pp

Returns & leverage

See full
Return on equity14.8%+1.5pp
Debt / equity0.1×0.0×
Current ratio1×0.0×

Segments

By product

See full
Clearingandtransactionfees$1.3B+7.8%
Market Data$208.0M+14.5%
Other Revenue$112.8M+1.3%

FAQ

When did CME Group report Q4 2025 earnings?
CME Group (CME) reported Q4 2025 earnings on February 4, 2026 before market open.
What were CME Group's Q4 2025 revenue and EPS?
CME Group reported revenue of $1.6B and eps of $2.77 for Q4 2025.
Did CME Group beat estimates in Q4 2025?
Revenue beat the consensus estimate of $1.6B by $1.4M. EPS beat the consensus estimate of $2.75 by $0.02.
How did CME Group's Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 8.1% from $1.5B a year earlier and eps grew 9.9% from $2.52.
Where can I find CME Group's Q4 2025 SEC filings?
You can read the 8-K earnings release (0001156375-26-000002) and the 10-K periodic report (0001156375-26-000009) directly on SEC EDGAR. The filing index links above go to sec.gov.